American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer - Wikidata - wikimedia - TriplyDB

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

http://www.wikidata.org/entity/Q57793991

about

The treatment landscape in thyroid cancer: a focus on cabozantinib Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations Highly prevalent TERT promoter mutations in aggressive thyroid cancers.Management of anaplastic thyroid cancer Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer Long-term results of radiotherapy in anaplastic thyroid cancer Is there a case for selective, rather than routine, preoperative laryngoscopy in thyroid surgery?Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.Update: the status of clinical trials with kinase inhibitors in thyroid cancer Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group Marginal treatment benefit in anaplastic thyroid cancer The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.A Case of a Rapidly Enlarging Neck Mass with Airway Compromise.Bioluminescent human thyrospheres allow noninvasive detection of anaplastic thyroid cancer growth and metastases in vivo Anaplastic thyroid carcinoma presenting as bilateral pleural effusion MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma Novel approaches in anaplastic thyroid cancer therapy Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.Complete remission of anaplastic thyroid carcinoma after concomitant treatment with docetaxel and radiotherapy Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).Completion thyroidectomy: predicting bilateral disease.The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer.Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF Anaplastic thyroid carcinoma presenting with gastric metastasis: a case report Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.Pitfall in immunohistochemical staining for thyroglobulin in case of thyroid metastasis from lung carcinoma Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer

P2860

Q26796404-42AC4BF3-F244-499A-9A50-E44353236987 Q27027491-B0F49A43-BD8D-42CC-9034-EA9040F3C743 Q27852353-98046418-2CF4-4706-984A-B1FAD69A1279 Q28080836-7A523FBE-F07E-4A81-9249-A5C54F7866A2 Q28547158-4989C137-3935-4BAD-BF9E-9968DE8088E7 Q30317480-361A1518-C4D9-4C56-A838-693F5F3B7BDB Q30418081-184CAC89-E53D-48ED-A71A-F2723735FF8F Q31151565-919DFD27-C052-4F5B-A9BD-587399E2AB8F Q33570056-C5E48387-E87B-40CF-9F02-189C1DFE6C16 Q33587905-FA510D40-4550-425C-BACE-007FBAA62FE4 Q33683989-BE2104EE-E00E-4B55-9A5B-C616D4761E05 Q33776640-2136A270-C77A-407A-A44E-90D8A2653773 Q33832214-16E711DB-EA89-4F6B-9B1B-3726291DFEE7 Q33842338-2D59D15A-7F86-4998-BA64-DE3FEC86C2C6 Q34031530-CAE38DBF-F610-42A9-9A8C-A5B0EE7B3490 Q34119098-406171A2-2F81-4627-992E-BA2972B017DE Q34425352-EBA9A7B5-96BE-4A2E-814E-882E17A3344D Q34458018-1161BCF1-7B36-4A4F-BCF8-DB7A47CE2933 Q35025521-97C3DE61-1DEB-4EF1-AA34-D6A712978A98 Q35055025-F53C1E3B-E38F-44D3-A348-7A2F31E7296B Q35055061-7077CF14-EEB0-46D8-94CF-37FC3F854B3C Q35144074-8F2097AE-DB26-485B-AAC6-A7C2ED23DA03 Q35234108-10B8DB41-E135-43C9-BE1C-3338C7BEF856 Q35441872-E137C2B6-A975-466D-A7B7-08198F6D72CF Q35578234-BBB5DEBC-8863-4FAF-B3EE-1B14133BD097 Q35622067-B48621CB-2ECC-45FF-A92C-A4197EFB194E Q35623044-B8B7214C-D0B1-44F8-8D34-A05D40F93FC8 Q35669034-41A35743-B5F9-476B-A834-BCBE51080A3B Q35780745-043F7E90-3108-4AA6-ABE3-589D8676D403 Q35872419-919B1B45-6A40-4697-AAC0-3FC5758C2894 Q35876617-BF86095D-5478-45FC-96D2-E733F07D0210 Q35914464-C93BC95F-49AB-4051-9414-C008AF2EB4DE Q36071997-7D41362F-499C-456D-828F-7F0497F44077 Q36171837-284AF02B-C2A8-4590-850E-F41016EC27EF Q36282782-07D1350D-6CC6-40CF-904E-FD965FDAB65E Q36370685-B7FBB1E7-956E-453E-8DA6-CD92767F8703 Q36618887-1B53DA12-6442-4A1D-ACBD-CD41D92BCF7D Q36801971-111BB0F2-D9FB-42ED-A354-27A4EEE90312 Q36919621-5819330A-4102-4679-B9A8-A3CE2D641984 Q37086070-9EBDAB34-9739-4B58-9C5B-013A537D7F3E

P2860

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

http://www.wikidata.org/entity/Q57793991

description

article

@en

im November 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2012

@uk

name

American Thyroid Association G ...... with Anaplastic Thyroid Cancer

@en

American Thyroid Association G ...... with Anaplastic Thyroid Cancer

@nl

type

label

American Thyroid Association G ...... with Anaplastic Thyroid Cancer

@en

American Thyroid Association G ...... with Anaplastic Thyroid Cancer

@nl

prefLabel

American Thyroid Association G ...... with Anaplastic Thyroid Cancer

@en

American Thyroid Association G ...... with Anaplastic Thyroid Cancer

@nl

P1433

Q57793991-2483973F-E093-47D3-A37D-8DCA83E91511

P1476

Q57793991-6A8B3848-134D-49CE-95BA-6B2B93EBCABF

P2093

Q57793991-0A53F3EC-5268-4D18-9F2B-3B2F70D67FCE

Q57793991-30C75BE9-1217-40D9-91DB-EC5491EED408

Q57793991-4FA531AD-9DD9-40F0-A6A5-42FDA5627527

Q57793991-546DE787-AD91-43FA-80C1-B17A8828DC8D

Q57793991-5DA62B1A-06CA-448D-969F-6ABC32B885F5

Q57793991-5FECCBB8-EBE1-4257-8561-4836B9CB0AA8

Q57793991-6BA65F23-46EF-4EA5-BAE8-D6916ECD4B24

Q57793991-9614E6DD-D602-4E41-95BA-2FBB12D47AAB

Q57793991-C64CB21B-378A-482F-8C37-11629A7B4C91

Q57793991-CFE824FA-FC6B-4406-B61F-32C7465ED563

P304

Q57793991-04DE7469-CFBF-41EF-B555-618717E3C093

P31

Q57793991-DBA5E683-F8FE-487C-9C6F-1CFC6C913E58

P356

Q57793991-096DB040-92DA-4FB8-B435-0A56AA0E1122

P433

Q57793991-393C485B-A374-4CB1-9E6F-EE39DD9CE5B2

P478

Q57793991-FC245DC6-4FBA-4F94-B4A1-76DE921B0D77

P50

Q57793991-FE079066-41E8-429B-B9CC-DDE6CACB4EBB

P577

Q57793991-17387CF9-6021-4B78-BF80-1A8A28CD8F65

P698

Q57793991-B3D06431-C2AD-4B57-BAFC-AB884182E845

P921

Q57793991-159D6141-38B3-4359-BADA-CB6746710487

Q57793991-7679C8FD-7EE8-4AEF-9B25-29F0498E6B7F

P356

P1433

P1476

American Thyroid Association g ...... with anaplastic thyroid cancer

@en

P2093

American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce

http://www.w3.org/2001/XMLSchema#string

Ashok R Shaha

http://www.w3.org/2001/XMLSchema#string

Electron Kebebew

http://www.w3.org/2001/XMLSchema#string

James D Brierley

http://www.w3.org/2001/XMLSchema#string

Keith C Bible

http://www.w3.org/2001/XMLSchema#string

Kenneth B Ain

http://www.w3.org/2001/XMLSchema#string

Kenneth D Burman

http://www.w3.org/2001/XMLSchema#string

M Sara Rosenthal

http://www.w3.org/2001/XMLSchema#string

Manisha H Shah

http://www.w3.org/2001/XMLSchema#string

Nancy Y Lee

http://www.w3.org/2001/XMLSchema#string

P304

1104-1139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/THY.2012.0302

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23130564

http://www.w3.org/2001/XMLSchema#string

P921